1. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients;Bastion;J Clin Oncol,1997
2. Natural history of and therapy for the indolent non-Hodgkin's lymphomas;Horning;Semin Oncol,1993
3. R-CVP vs R-CHOP vs R-FM for the initial treatment of patients with advanced stage follicular lymphoma;Federico;Ann Oncol,2011
4. Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a multicenter study;Kahl;Cancer,2010
5. Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphoma;Cheson;Clin Lymphoma Myeloma Leuk,2010